Document is current

Any future updates will be listed below

Evidence that Formulations of the Selective MAO-B Inhibitor, Selegiline, which Bypass First-Pass Metabolism, also Inhibit MAO-A in the Human Brain

Crossref DOI link: https://doi.org/10.1038/npp.2014.214

Published Online: 2014-09-24

Published Print: 2015-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark